Company Filing History:
Years Active: 2003
Title: Innovations by Niklaus Künzle in Enantioselective Hydrogenation
Introduction
Niklaus Künzle, an accomplished inventor located in Wil, Switzerland, has made significant contributions to the field of chemistry. With one notable patent to his name, Künzle has focused his efforts on advancing processes that enhance the production and efficiency of chemical compounds.
Latest Patents
Künzle's patent, titled "Continuous process for the enantioselective hydrogenation of alpha ketocarbonyl compounds," is a remarkable innovation. This invention pertains to a continuous process for the enantioselective catalytic hydrogenation of alpha ketocarbonyl compounds, including alpha ketoesters and alpha ketolactones. The process ultimately leads to the production of alpha hydroxy carbonyl compounds, contributing valuable insights and alternatives to traditional hydrogenation methods.
Career Highlights
Niklaus Künzle is currently associated with Roche Vitamins Inc., a prominent player in the industry known for its commitment to health and nutritional solutions. His work at Roche has allowed him to apply his expertise in chemical processes, thereby enhancing the company's research and development capabilities in vitamin production.
Collaborations
Throughout his career, Künzle has collaborated with several distinguished professionals, including Alfons Baiker and Tamas Mallat. These partnerships exemplify his ability to work alongside renowned colleagues, contributing to the advancement of innovative chemical processes and solutions.
Conclusion
Niklaus Künzle's contributions to the field of chemistry, particularly in the area of enantioselective hydrogenation, highlight the importance of innovation in advancing scientific knowledge and practical applications. His ongoing work at Roche Vitamins Inc. and collaboration with esteemed peers positions him as a notable figure in the realm of inventions and patents.